Center for Reproductive Rights
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

Amicus Briefs: Alliance for Hippocratic Medicine v. FDA

Menu Close Menu Close icon
Donate
Nationwide Threat to Medication Abortion

Amicus Briefs: Alliance for Hippocratic Medicine v. FDA

Hundreds of individuals and organizations joined in submitting amicus briefs supporting the FDA's actions on the abortion medication mifepristone. On March 26, 2024, the U.S. Supreme Court will hear arguments about lower court rulings that threaten access to the drug throughout the U.S.

Summary

As listed below, a broad range of experts, including the Center for Reproductive Rights, have filed amicus briefs before the U.S. Supreme Court and the Fifth Circuit Court of Appeals in Alliance for Hippocratic Medicine v. FDA supporting the FDA’s actions on mifepristone and urging the courts to block lower court rulings that threaten access to the medication nationwide.

Submitted by leading medical and health organizations; pharmaceutical companies; current and former government officials; members of Congress; reproductive health, rights and justice advocates; and many other experts, the briefs argue that allowing the lower court decisions to take effect would upend the FDA’s scientific-based process in approving drugs; risk other drugs that have been approved by the agency; harm patient health; and interfere with patient decision-making. In addition, several briefs outline mifepristone’s proven safety and efficacy since it was first approved more than two decades ago.

Below are the briefs that have been filed in this case.

U.S. Supreme Court Amicus Briefs, 01.30.24

Fifth Circuit Amicus Briefs, 05.01.23

U.S. Supreme Court Amicus Briefs, 04.14.23

Fifth Circuit Amicus Briefs, 04.11.23